Rachel C. Orscheln, M.D.  orscheln_r@kids.wustl.edu

Assistant Professor of Pediatrics, Infectious Diseases
Infectious Diseases

phone: (314) 454-6050

Clinical Interests

Dr. Orscheln is the director of ambulatory pediatric infectious diseases and the International Adoption Center at St. Louis Children’s Hospital. Her special clinical interests include adoption medicine, international health, and orthopedic infections. Her research interests include prevention of staphylococcal infections and treatment of orthopedic infections in children.


  • B.S., Honors Certificate, University of Missouri-Columbia1994
  • M.D., Cum Laude , University of Missouri School of Medicine1998


  • Resident, St. Louis Children's Hospital1998 - 2001
  • Fellow, Washington University School of Medicine2001 - 2005

Licensure and Board Certification

  • Pediatric Advanced Life Support1998
  • Neonatal Advanced Life Support1998
  • American Board of Pediatrics2001
  • MO, Physician and Surgeon2001
  • Pediatric Infectious Diseases2005


  • State of Missouri Bright Flight Scholarship1990 - 1994
  • University of Missouri Curators' Scholarship1990 - 1994
  • Honors Certificate for University of Missouri Honors College, Graduated Cum Laude from the University of Missouri- School of Medicine1994
  • Phi Beta Kappa1994
  • American Academy of Pediatrics Outstanding Resident Award2001
  • Best Doctors in St. Louis2015 - 2016
  • Best Doctors in St. Louis2016 - 2017

Recent Publications view all (6)

Publication Co-Authors

  1. Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM, Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013;381(9872):1099-106. doi:10.1016/S0140-6736(12)61687-0  PMID:23363666  
  2. Orscheln RC, Hunstad DA, Fritz SA, Loughman JA, Mitchell K, Storch EK, Gaudreault M, Sellenriek PL, Armstrong JR, Mardis ER, Storch GA. contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis. 2009;49(4):536-42. doi:10.1086/600881  PMCID:PMC2965061  PMID:19589082  
  3. Elizur A, Orscheln RC, Ferkol TW, Dunne WM Jr, Storch GA, Cannon CL. Transmission of Panton-Valentine leukocidin-positive Staphylococcus aureus between patients with cystic fibrosis. J Pediatr. 2007;151(1):90-2. doi:10.1016/j.jpeds.2007.04.016  PMID:17586197  
  4. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM Jr, Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131(6):1718-25. doi:10.1378/chest.06-2756  PMID:17400676  
  5. Liao RS, Storch GA, Buller RS, Orscheln RC, Mardis ER, Armstrong JR, Dunne WM Jr. Blinded comparison of repetitive-sequence PCR and multilocus sequence typing for genotyping methicillin-resistant Staphylococcus aureus isolates from a children's hospital in St. Louis, Missouri. J Clin Microbiol. 2006;44(6):2254-7. doi:10.1128/JCM.00690-06  PMCID:PMC1489435  PMID:16757633  
  6. Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis. 2005;191(8):1272-9. doi:10.1086/428856  PMID:15776373  
Wash U School of Medicine
Children's Hospital St. Louis
Children's Discovery Institute
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130